盆腔炎性疾病与上皮性卵巢癌风险:瑞典全国人群病例对照研究
这项瑞典全国人群病例对照研究纳入1999至2020年诊断的上皮性卵巢癌患者15072例及按年龄和居住区匹配的对照141322例,发现既往盆腔炎性疾病与上皮性卵巢癌风险升高相关(调整OR 1.39,95%CI 1.17-1.66),且随盆腔炎发作次数呈剂量反应关系(P趋势<.001)。
要点
- 既往盆腔炎性疾病与上皮性卵巢癌风险升高相关,调整OR 1.39(95%CI 1.17-1.66)。
- 盆腔炎性疾病与浆液性癌风险升高相关,调整OR 1.46(95%CI 1.18-1.80)。
- 盆腔炎发作次数与上皮性卵巢癌风险呈剂量反应关系(P趋势<.001)。
核心结论
- 既往盆腔炎性疾病与上皮性卵巢癌风险升高相关,且存在剂量反应关系。
- 组织学亚型分析显示盆腔炎性疾病与浆液性上皮性卵巢癌及高级别浆液性癌风险升高相关,也可能与透明细胞癌相关,但与其他组织学亚型无显著关联。
- 上生殖道感染和炎症可能具有严重的长期后果,包括上皮性卵巢癌。
研究设计与样本
- 瑞典全国人群病例对照研究,纳入1999至2020年诊断的上皮性卵巢癌女性15072例,按年龄和居住区匹配对照141322例(每例10名对照)。
- 通过瑞典全国登记库获取既往盆腔炎性疾病及潜在混杂因素(年龄、产次、教育水平、既往妇科手术)数据,采用条件logistic回归估计调整OR及95%CI。
- 对2015至2020年诊断的上皮性卵巢癌女性亚组进行组织学亚型分析,并额外调整激素避孕药和绝经激素治疗。
主要发现
- 共168例病例(1.1%)和1270名对照(0.9%)诊断为盆腔炎性疾病。
- 全研究人群中,既往盆腔炎性疾病与上皮性卵巢癌风险升高相关(调整OR 1.39;95%CI 1.17-1.66),与浆液性癌风险升高相关(调整OR 1.46;95%CI 1.18-1.80)。
- 2015至2020年诊断亚组中,盆腔炎性疾病与高级别浆液性癌风险升高相关(调整OR 1.43;95%CI 1.01-2.04)。
- 其他组织学亚型的调整OR分别为:子宫内膜样癌0.13(95%CI 0.02-1.06)、黏液性癌1.55(95%CI 0.56-4.29)、透明细胞癌2.30(95%CI 0.90-5.86)。
- 盆腔炎性疾病发作次数与上皮性卵巢癌风险之间存在剂量反应关系(P趋势<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Epithelial ovarian cancer is an insidious disease, and women are often diagnosed when the disease is beyond curative treatment. Accordingly, identifying modifiable risk factors is of paramount importance. Inflammation predisposes an individual to cancer in various organs, but whether pelvic inflammatory disease is associated with an increased risk of epithelial ovarian cancer has not been fully determined. OBJECTIVE: This study aimed to investigate a possible association between clinically verified pelvic inflammatory disease and the risk of epithelial ovarian cancer. STUDY DESIGN: In this national population-based case-control study, all women in Sweden diagnosed with epithelial ovarian cancer between 1999 and 2020 and 10 controls for each were identified, matched for age and residential district. Using several Swedish nationwide registers, data on previous pelvic inflammatory disease and potential confounding factors (age, parity, educational level, and previous gynecologic surgery) were retrieved. Adjusted odds ratios and 95% confidence intervals were estimated using conditional logistic regression. Histotype-specific analyses were performed for the subgroup of women diagnosed with epithelial ovarian cancer between 2015 and 2020. Moreover, hormonal contraceptives and menopausal hormone therapy were adjusted in addition to the aforementioned confounders. RESULTS: This study included 15,072 women with epithelial ovarian cancer and 141,322 controls. Most women (9102 [60.4%]) had serous carcinoma. In a subgroup of cases diagnosed between 2015 and 2020, high-grade serous carcinoma (2319 [60.0%]) was identified. A total of 168 cases (1.1%) and 1270 controls (0.9%) were diagnosed with pelvic inflammatory disease. Previous pelvic inflammatory disease was associated with an increased risk of epithelial ovarian cancer (adjusted odds ratio, 1.39; 95% confidence interval, 1.17-1.66) and serous carcinoma (adjusted odds ratio, 1.46; 95% confidence interval, 1.18-1.80) for the entire study population. For the subgroup of women diagnosed in 2015-2020, pelvic inflammatory disease was associated with high-grade serous carcinoma (adjusted odds ratio, 1.43; 95% confidence interval, 1.01-2.04). The odds ratios of the other histotypes were as follows: endometrioid (adjusted odds ratio, 0.13; 95% confidence interval, 0.02-1.06), mucinous (adjusted odds ratio, 1.55; 95% confidence interval, 0.56-4.29), and clear cell carcinoma (adjusted odds ratio, 2.30; 95% confidence interval, 0.90-5.86). A dose-response relationship was observed between the number of pelvic inflammatory disease episodes and the risk of epithelial ovarian cancer (Ptrend<.001). CONCLUSION: A history of pelvic inflammatory disease is associated with an increased risk of epithelial ovarian cancer and a dose-response relationship is evident. Histotype-specific analyses show an association with increased risk of serous epithelial ovarian cancer and high-grade serous carcinoma and potentially also with clear cell carcinoma, but there is no significant association with other histotypes. Infection and inflammation of the upper reproductive tract might have serious long-term consequences, including epithelial ovarian cancer.
引用
- Jonsson S, Jonsson H, Lundin E, et al. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden. Am J Obstet Gynecol. 2023. PMID: 37778677. doi:10.1016/j.ajog.2023.09.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。